PET scan to measure inflammation in Crohn's and colitis
Treatments studied
Part of Digestive system clinical trials.
This trial uses a special PET scan called FAPi-PET to look for inflammation and scarring in the gut. It may help doctors better understand your condition and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have been diagnosed with Crohn's disease or ulcerative colitis.
- Your disease must be active, shown by symptoms like diarrhea, belly pain, or by blood tests or scope results.
- You cannot be pregnant.
- You must not have had any IBD-related surgery in the past 5 years.
- You cannot have colorectal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.
This trial tests a new type of PET scan (Ga68-FAPI-46) to better see if cancer from the colon, rectum, or ovary has spread to the lining of the belly. If you are already scheduled for surgery to remove these cancer spots, this scan may help your doctors plan a more complete operation.
This trial tests a new type of PET scan to see if it can accurately spot inflamed or damaged areas in the intestines of people with inflammatory bowel disease (IBD). If it works, it could help doctors track disease activity without relying only on invasive tests.
This study tests a new PET scan with a tracer called 68Ga-FAPI-46 to see how well it can find and measure scarring (fibrosis) in the small bowel caused by Crohn's disease. It may help doctors better understand and manage bowel damage.
This study uses a special imaging tracer (FAPI) to find scar tissue in the small intestine of people with Crohn's disease. The goal is to see if this scan can help doctors better understand which parts of the intestine are scarred, which may guide treatment decisions.
This trial uses a special PET/CT scan with a tracer called 68Ga-FAPI-46 to see if it can better detect inflammation and scarring (fibrosis) in people with chronic diseases like scleroderma, pulmonary fibrosis, or rheumatoid arthritis. The goal is to improve diagnosis and monitoring.
Hear when a new IBD (Inflammatory Bowel Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.